Related Experiment Video
Updated: Aug 24, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var
Anja T R Jensen1, Pamela Magistrado, Sarah Sharp
1Department of Medical Microbiology and Immunology, The Panum Institute, Building 24-2, Blegdamsvej 3, 2200 Copenhagen, Denmark. atrj@biobase.dk
Abstract:
Parasite-encoded variant surface antigens (VSAs) like the var gene-encoded Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family are responsible for antigenic variation and infected red blood cell (RBC) cytoadhesion in P. falciparum malaria. Parasites causing severe malaria in nonimmune patients tend to express a restricted subset of VSA (VSA(SM)) that differs from VSA associated with uncomplicated malaria and asymptomatic infection (VSA(UM)). We compared var gene transcription in unselected P. falciparum clone 3D7 expressing VSA(UM) to in vitro-selected sublines expressing VSA(SM) to identify PfEMP1 responsible for the VSA(SM) phenotype. Expression of VSA(SM) was accompanied by up-regulation of Group A var genes. The most prominently up-regulated Group A gene (PFD1235w/MAL7P1.1) was translated into a protein expressed on the infected RBC surface. The proteins encoded by Group A var genes, such as PFD1235w/MAL7P1.1, appear to be involved in the pathogenesis of severe disease and are thus attractive candidates for a vaccine against life-threatening P. falciparum malaria.
Insights
Variant surface antigens (VSAs) in Plasmodium falciparum malaria, specifically PfEMP1, are linked to severe disease. Group A var genes, like PFD1235w/MAL7P1.1, are upregulated in severe malaria and are potential vaccine targets.
Area of Science:
- Malariology
- Immunology
- Molecular Biology
Background:
- Plasmodium falciparum malaria pathogenesis involves parasite-encoded variant surface antigens (VSAs).
- VSAs, particularly the PfEMP1 family, mediate antigenic variation and red blood cell cytoadhesion.
- Severe malaria is associated with a distinct VSA subset (VSA(SM)) compared to uncomplicated malaria (VSA(UM)).
Purpose of the Study:
- To identify the specific PfEMP1 proteins responsible for the VSA(SM) phenotype associated with severe malaria.
- To compare var gene transcription between parasites expressing VSA(UM) and VSA(SM).
Main Methods:
- Comparative analysis of var gene transcription in P. falciparum clone 3D7 (VSA(UM)) and in vitro-selected sublines (VSA(SM)).
- Identification and characterization of upregulated Group A var genes and their encoded proteins.
Main Results:
- Expression of VSA(SM) correlated with the upregulation of Group A var genes.
- The Group A gene PFD1235w/MAL7P1.1 was significantly upregulated and its protein product expressed on the infected RBC surface.
- Group A var gene products, including PFD1235w/MAL7P1.1, are implicated in severe malaria pathogenesis.
Conclusions:
- Group A var genes encode PfEMP1 proteins crucial for the VSA(SM) phenotype and severe malaria.
- PFD1235w/MAL7P1.1 is a key candidate for a malaria vaccine targeting severe P. falciparum infections.
Related Concept Videos
Malaria
Diversity of Protists II
Symbiosis
Fungal Phylum Microsporidia
Yellow Fever

